Package 83457-101-01

{"route": ["SUBCUTANEOUS"], "spl_id": "04bedd16-44e8-4761-bb65-d4678c4013af", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "unii": ["FYS6T7F842"], "rxcui": ["2641653", "2641654", "2641655", "2641658", "2641660", "2641661", "2641662", "2641663", "2641664", "2641665", "2641670", "2641671", "2665419", "2665422", "2665424", "2665426"], "spl_set_id": ["3e303a4a-980b-4f2a-9d03-786928758637"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Cordavis Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, GLASS in 1 CARTON (83457-101-01)  / .4 mL in 1 SYRINGE, GLASS", "package_ndc": "83457-101-01", "marketing_start_date": "20230921"}], "brand_name": "HYRIMOZ", "product_id": "83457-101_04bedd16-44e8-4761-bb65-d4678c4013af", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "83457-101", "generic_name": "adalimumab-adaz", "labeler_name": "Cordavis Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HYRIMOZ", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.4mL"}], "application_number": "BLA761071", "marketing_category": "BLA", "marketing_start_date": "20230921", "listing_expiration_date": "20271231"}